Health ❯ Pharmaceuticals

Biotechnology

Clinical Trials Collaborations Cancer Treatments Insulin Production Patent Law Regulatory Approvals Biotech Companies Covid-19 Vaccines Nanomedicine Pharma Companies Viral Therapies RNA Therapeutics Antisense Oligonucleotides AI in Medicine Investment in Healthcare Cancer Treatment Vaccine Development Bioactive Compounds Drug Development Antibody Research

Rani Therapeutics and Chugai Sign Oral Biologics Collaboration Worth Up to $1.085 Billion

Technology transfer kicks off next, with a concurrent $60.3 million PIPE expected to fund Rani into 2028.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2025 Mina Labs Inc.